Price: R1,999 (incl. VAT)
Strength: 1.34mg/ml (1.5ml pen) – 2mg total
Approx. duration: ±6 weeks (new patient: 0.25mg x4, 0.5mg x2)
What it is
Semaglutide is a GLP-1 receptor agonist that helps reduce appetite, slow stomach emptying and stabilise blood sugar, making it a powerful tool for medical weight loss. By acting on the same receptors as your natural GLP-1 hormone, it helps you feel satisfied on smaller portions, reduces cravings and smooths out post-meal glucose spikes. This 1mg pen is designed for standard GLP-1 programmes with weekly injections, and is ideal for clients who struggle with overeating, emotional eating or plateaued weight loss despite lifestyle changes.
Used for
- Medically supervised weight-loss programmes
- Reducing appetite, portion sizes and snacking
- Central/abdominal fat and metabolic syndrome
- Supporting blood-sugar control in overweight clients
- Long-term weight-maintenance after initial loss
Price: R3,299 (incl. VAT)
Strength: 1.34mg/ml (3ml pen) – 4mg total
Approx. duration: ±8 weeks new / ~4 weeks at 1mg maintenance
What it is
This higher-strength semaglutide pen is intended for clients who have titrated up and require higher maintenance doses for continued weight loss and metabolic control. It delivers the same GLP-1 effects—reduced appetite, slower gastric emptying and improved post-meal glucose handling—but with more total drug per pen, extending duration at higher doses. It’s well suited to clients on established GLP-1 protocols, those with significant starting weight, or those needing prolonged treatment to stabilise results.
Used for
- Ongoing/advanced semaglutide weight-loss plans
- Clients at higher weekly doses (e.g. 1–2mg)
- Larger or higher-risk patients needing longer treatment horizons
- Reducing visceral fat and waist circumference
- Supporting cardiometabolic risk reduction over months
Price: R4,299 (incl. VAT)
Strength: 1mg/0.6ml (2.4ml pen) – 4mg total
Approx. duration: ±8 weeks (depending on script and titration)
What it is
Ozempic is the original branded form of semaglutide from Novo Nordisk, widely used globally for type 2 diabetes management and medical weight loss. It acts on GLP-1 receptors to promote satiety, reduce food intake and improve blood-sugar control, which often translates into steady, sustainable weight reduction. This pen is ideal for clients who prefer the reassurance of the originator brand, or whose doctor has specifically recommended Ozempic for metabolic or diabetic reasons.
Used for
- Medical weight-loss where branded Ozempic is preferred
- Type 2 diabetes support under medical care
- Clients who want brand-name Ozempic specifically
- Appetite and craving control alongside lifestyle changes
- Reducing long-term cardiometabolic risk
At mobivIVe, doctor-reviewed, SAHPRA-registered Semagard semaglutide starts from R1,999 per pen, with branded Ozempic (2.4ml) at R4,299 and Tirzepatide (Mounjaro) also available. A telephone or virtual doctor consultation is required for all GLP-1 medicines before a script can be issued.
Yes. Semaglutide is a SAHPRA-regulated prescription medicine and cannot be sold without a consultation. You complete a short medical questionnaire and then have a telephone or virtual consultation with our registered doctor, who issues a script if it is safe and suitable for you.
Yes. Once your script is approved, your prefilled pen is couriered discreetly anywhere in South Africa.
Both contain the same active molecule, semaglutide. Ozempic is the branded, imported product. Your doctor prescribes and doses the option that is right for you on your valid script, delivered nationwide.
In the STEP clinical trial, once-weekly semaglutide produced an average of about 15% body-weight loss over 68 weeks (New England Journal of Medicine). Individual results vary by dose, lifestyle and adherence, and your doctor will set realistic, personalised expectations. Semaglutide works best combined with nutrition and activity, which our team supports.